Skip to main content
Tarsus Pharmaceuticals, Inc. logo

Tarsus Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · TARS ISIN · US87650L1035 US Manufacturing
Filings indexed 576 across all filing types
Latest filing 2023-03-17 Director's Dealing
Country US United States of America
Listing US TARS

About Tarsus Pharmaceuticals, Inc.

https://www.tarsusrx.com/

Tarsus Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic candidates for diseases with limited treatment options. The company's initial focus is on eye care. Its lead product, XDEMVY® (lotilaner ophthalmic solution) 0.25%, is the first and only FDA-approved treatment for Demodex blepharitis. Tarsus is also advancing a pipeline of potential treatments for other conditions with high unmet needs, including ocular rosacea, Lyme disease prevention, and other indications across dermatology and infectious diseases.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2023-03-17 English
FORM 4 SUBMISSION
Director's Dealing
2023-03-17 English
FORM 4 SUBMISSION
Director's Dealing
2023-03-17 English
FORM 4
Director's Dealing
2023-03-17 English
FORM 4
Director's Dealing
2023-03-17 English
S-8
Capital/Financing Update Classification · 95% confidence The document is a Form S-8 Registration Statement filed with the SEC by Tarsus Pharmaceuticals, Inc. It registers additional shares under the company's 2020 Equity Incentive Plan and 2020 Employee Stock Purchase Plan. Form S-8 is a specific SEC filing used to register securities to be offered under employee benefit plans. The document includes legal and procedural information about the registration, indemnification clauses, and references to other filings but does not contain financial statements or earnings data. It is not an annual report, earnings release, or any other financial report type. It is a capital/financing related filing concerning registration of shares for employee plans, which fits the Capital/Financing Update category (CAP).
2023-03-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.